Recruiting
Phase 3

Hypofractionated Radiotherapy

Sponsor:

Ontario Clinical Oncology Group (OCOG)

Code:

NCT04228991

Conditions

Breast Neoplasms

Radiotherapy

Lymphedema

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Locoregional radiation treatment - Conventional fractionation

Locoregional radiation treatment - Hypofractionation

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-17. This information was provided to ClinicalTrials.gov by Ontario Clinical Oncology Group (OCOG) on 2025-05-09.